Both in Biotechnology
Inhibikase Therapeutics vs Cabaletta Bio
Over the past year IKT returned 0.0% and CABA returned −52.3%; their daily moves had a correlation of 0.36.
IKT 0.0% CABA −52.3%Growth of $1, one year, split-adjusted
| Metric | IKT | CABA |
|---|---|---|
| Price | $1.48 | $1.42 |
| Market cap | $206.5M | $240.8M |
| Today | −3.90% | −0.70% |
| 1 month | −26.0% | −31.7% |
| 6 months | −23.3% | −65.8% |
| Year to date | −27.8% | −35.2% |
| 1 year | +0.7% | −60.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $159.0M | $205.1M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 78.7% |
| Short % of float | 17.8% | 27.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).